Use of inpatient palliative care in metastatic urethral cancer.
Urol Oncol
; 42(7): 221.e17-221.e22, 2024 Jul.
Article
in En
| MEDLINE
| ID: mdl-38627106
ABSTRACT
BACKGROUND:
In metastatic urethral cancer, temporal trends, and patterns of inpatient palliative care (IPC) use are unknown.METHODS:
Relying on the National Inpatient Sample (2006-2019), metastatic urethral cancer patients were stratified according to IPC use. Estimated annual percentage changes (EAPC) analyses and multivariable logistic regression models (LRM) for the prediction of IPC use were fitted.RESULTS:
Of 1,106 metastatic urethral cancer patients, 199 (18%) received IPC. IPC use increased from 5.8 to 28.0% over time in the overall cohort (EAPC +9.8%; P < 0.001), from <12.5 to 35.1% (EAPC +11.2%; P < 0.001), and from <12.5 to 24.7% (EAPC +9.4%; Pâ¯=â¯0.01) in respectively females and males. Lowest IPC rates were recorded in the Midwest (13.5%) vs. highest in the South (22.5%). IPC patients were more frequently female (44 vs. 37%), and more frequently exhibited bone metastases (45 vs. 34%). In multivariable LRM, female sex (multivariable odds ratio [OR] 1.46, 95% confidence interval [CI] 1.05-2.02; Pâ¯=â¯0.02), and bone metastases (OR 1.46, 95%CI 1.02-2.10; Pâ¯=â¯0.04) independently predicted higher IPC rates. Conversely, hospitalization in the Midwest (OR 0.53, 95%CI 0.31-0.91; Pâ¯=â¯0.02), and in the Northeast (OR 0.48, 95%CI 0.28-0.82; Pâ¯=â¯0.01) were both associated with lower IPC use than hospitalization in the West.CONCLUSION:
IPC use in metastatic urethral cancer increased from a marginal rate of 5.8% to as high as 28%. Ideally, differences according to sex, metastatic site, and region should be addressed to improve IPC use rates.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Palliative Care
/
Urethral Neoplasms
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Urol Oncol
/
Urol. oncol
/
Urologic oncology
Journal subject:
NEOPLASIAS
/
UROLOGIA
Year:
2024
Type:
Article